Study on Xeomin shots to prevent migraines
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial tests if Xeomin injections can help prevent episodic migraines in people who have 6 to 14 migraine days per month. It's for those under 50 when their migraines started and who can tell migraine from other headaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have migraines with or without aura for at least 12 months
- Started having migraines before age 50
- In the past 3 months, had 14 or fewer headache days and 6 to 14 migraine days per month
- No chronic migraines (15+ headache days per month)
- Currently taking no more than 1 daily migraine prevention pill
- If you've used migraine prevention shots (like Aimovig or Emgality), it's been at least 5 months since your last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests eptinezumab to reduce migraine attacks in children who have episodic migraine (not daily chronic migraine). It may help by lowering the number of headache days and migraine days over time. You must complete a headache diary during screening to be considered.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This trial tests whether neurofeedback, a technique that helps you control your brain activity, can reduce the frequency of migraine attacks in people with episodic migraine. If you have 5 to 14 migraine days per month, this study might help you manage your migraines without medication.
This study tests whether chiropractic adjustments (spinal manipulation) can help reduce the number of migraine days you have each month. You will be randomly assigned to one of two groups: one group gets chiropractic care plus usual care, the other gets a sham (fake) treatment plus usual care, so researchers can see if the real adjustments work better.
This Phase 2 trial tests whether nerve block injections can reduce pain from episodic migraines. It may help some people who get frequent migraine attacks but are not also using certain migraine preventions or strong pain medicines.
This study looks for new biological markers in people whose migraines don't respond to standard treatments. It aims to better understand why some migraines are hard to treat and may help guide future therapies.
Hear when a new Episodic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.